Definium Therapeutics, Inc.
DFTX
$17.77
$0.130.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.36% | -29.20% | -24.74% | -15.81% | 174.55% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.93% | 66.37% | 34.69% | 194.97% | 89.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 48.90% | -27.90% | -23.64% | -13.22% | 171.12% |
|
|
|||||
| Total Current Assets | 48.90% | -27.90% | -23.64% | -13.22% | 171.12% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.62% | 11.56% | 119.85% | 320.83% | 173.66% |
| Total Assets | 45.66% | -25.91% | -1.14% | -0.08% | 142.61% |
|
|
|||||
| Total Accounts Payable | 166.02% | 277.52% | 43.60% | -70.14% | -51.40% |
| Total Accrued Expenses | 59.37% | 115.40% | 79.08% | 15.27% | 10.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 70.37% | 71.48% | -38.25% | -64.96% | 45.73% |
| Total Other Current Liabilities | 70.37% | 71.48% | -38.25% | -64.96% | 45.73% |
| Total Current Liabilities | 71.69% | 96.65% | -9.30% | -53.30% | 20.48% |
|
|
|||||
| Total Current Liabilities | 71.69% | 96.65% | -9.30% | -53.30% | 20.48% |
| Long-Term Debt | 85.68% | 66.12% | 69.85% | 55.29% | 54.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 77.54% | 84.66% | 20.56% | -33.92% | 30.81% |
|
|
|||||
| Common Stock & APIC | 42.91% | 5.81% | 17.75% | 19.34% | 73.78% |
| Retained Earnings | -46.08% | -46.16% | -32.68% | -22.53% | -37.45% |
| Treasury Stock & Other | 32.48% | 21.92% | -3.12% | -4.07% | 138.78% |
| Total Common Equity | 37.64% | -50.19% | -8.24% | 13.64% | 209.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.64% | -50.19% | -8.24% | 13.64% | 209.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.64% | -50.19% | -8.24% | 13.64% | 209.02% |
|
|
|||||